当前位置:首页 > 文献互助 > 互助详情

First-in-class Claudin 18.2 targeting radiopeptide, 64Cu-PD-29875 and 177Lu-PD-29875, exhibit promising theranostic potential in a pancreatic cancer xenograft …复制

用户sToGMn7iJdc8 13小时前 10 10 求助中 帖子自动结束时间: 2025-12-12 20:54:38

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性,不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接: https://aacrjournals.org/cancerres/article/85/8_Supplement_1/577/754725/Abstract-577-First-in-class-Claudin-18-2-targeting复制

其他信息:

S Tsuchida, Y Mizukoshi, S Kato, H Inaba…
Cancer …, 2025
aacrjournals.org
… PD-29875 is selectively binding to hCLDN18.2. In in vivo biodistribution experiment, 64 Cu-PD-29875 and 177 Lu-PD-29875 … lower, suggesting PD-29875 distinguishes physiological …

互助时间线

2025-12-07 20:54:38 [发起求助]